Evaluation of the therapeutic potential of synthetic miRNA-223-3p analog in a rat model of severe asthma
2023/51/D/NZ4/01095
Keywords
Descriptors
- NZ5_03: Patogeneza chorób człowieka
- NZ4_12: Inne zagadnienia pokrewne
Panel
NZ4 – Biology of tissues, organs and organisms: morphology and functions of animal's and human's systems, organs and organisms, experimental medicine, basics of neurology
Host institution
Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 4
Call
SONATA 19 – announced on 2023-09-18
- Amount awarded
- 2 640 080 PLN
- Project start date
- 2024-07-30
- Project end date
- 2027-07-29
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (1)
-
An optimized QIAzol‑based protocol for simultaneous miRNA, RNA, and protein isolation from precision‑cut lung slices (PCLS)
- Authors:
- Wojciech Langwiński, Joanna Nowakowska, Kosma Sakrajda, Kamil Ziarniak, Zuzanna Stachowiak, Maria Kachel, Beata Narożna, Aleksandra Szczepankiewicz
- Academic press:
- Respiratory Research (year: 2024, volume: 25, pages: 422), Publisher: Springer Nature
- Status:
- Published
- DOI:
- 10.1186/s12931-024-03026-3 – link to the publication